Cluster-Based Analysis of Lipid Profiles and Inflammation in Association With Cardiovascular Disease Incidence and Mortality: A 17.5-Year Longitudinal Study
- PMID: 40101020
- PMCID: PMC11917929
- DOI: 10.1111/jch.70035
Cluster-Based Analysis of Lipid Profiles and Inflammation in Association With Cardiovascular Disease Incidence and Mortality: A 17.5-Year Longitudinal Study
Abstract
Cardiovascular mortality is a leading cause of global deaths, with aging, dyslipidemia, and inflammation recognized as key risk factors. This study aimed to identify distinct cardiovascular risk profiles using cluster analysis based on lipid profiles and inflammatory markers in a large cohort of middle-aged Korean adults. Our analysis included 8115 participants without cardiovascular disease (CVD) at baseline from the Korean Genome and Epidemiology Study. We applied the K-means clustering algorithm to conduct a cluster analysis of six normalized variables: age, total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), non-HDL-C, and CRP. Multivariable Cox proportional-hazard regression analysis was performed to assess the hazard ratio with 95% confidence interval for CVD incidence, CVD mortality, major adverse cardiac event (MACE) mortality, and all-cause mortality. Four clusters were identified based on age, lipids (TC, TG, HDL-C, non-HDL-C), and CRP. Cluster 1 (older age, high CRP) and cluster 2 (high TC, non-HDL-C, insulin resistance) had the highest risks for new-onset CVD, while cluster 1 had the highest risks for all-cause and cardiovascular mortality. Cluster 3 (high HDL-C) showed a lower CVD risk, while cluster 4 (younger age, favorable lipid profile) had the lowest risk across all outcomes. This study highlighted the combined impact of aging, dyslipidemia, and inflammation on CVD risk. The clusters with older age and high inflammation or dyslipidemia had the highest cardiovascular risks, emphasizing the importance of managing these factors in high-risk populations.
Keywords: aging; cardiovascular disease; cluster analysis; dyslipidemia; inflammation; mortality.
© 2025 The Author(s). The Journal of Clinical Hypertension published by Wiley Periodicals LLC.
Conflict of interest statement
The authors declare no competing interests.
Figures



References
-
- Mensah G. A., Roth G. A., and Fuster V., “The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond,” Journal of the American College of Cardiology 74, no. 20 (2019): 2529–2532. - PubMed
-
- World Health Organization . Cardiovascular Diseases (CVDs) Fact Sheet. Available at:, https://www.who.int/news‐room/fact‐sheets/detail/cardiovascular‐diseases...), accessed December 6, 2023.
-
- Libby P., Buring J. E., Badimon L., et al., “Atherosclerosis,” Nature Reviews Disease Primers 5, no. 1 (2019): 56. - PubMed
-
- Statistics Korea . Causes of Death Statistics in 2022 (Daejeon, 2023).
-
- Arnett D. K., Blumenthal R. S., Albert M. A., et al., “2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines,” Circulation 140, no. 11 (2019): e563–e595. - PMC - PubMed
MeSH terms
Substances
Grants and funding
- Ministry of SMEs and Startups
- Korea Technology and Promotion Agency for SMEs (TIPA)
- S3370378/Regional Specialized Industry Development Plus Program
- Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, and Forestry (IPET)
- High Value-Added Food Technology Development Program
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous